PubMed、Scopus、および Web のサイエンス データベースを使用した書誌分析の比較

Executive Industry Relevance

Bibliometric analysis enables biopharma R&D teams to assess research output, identify emerging trends, and evaluate competitive landscapes across therapeutic areas. By comparing database coverage and search capabilities, organizations can optimize literature surveillance for target validation and mechanistic de-risking. This protocol supports data-driven decision-making in early discovery and portfolio prioritization.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Interrogate therapeutic hypotheses by mapping publication trends in disease mechanisms and pathway involvement.
• Operational Value: Identify high-impact journals and key opinion leaders to inform target selection and validation strategies.
• Predictive Value: Assess research activity levels to gauge target maturity and de-risk biological assumptions.

Screening & Assay Development

• Scientific Value: Leverage database-specific tools like MeSH in PubMed for precise keyword optimization in assay-related literature searches.
• Operational Value: Use Scopus and Web of Science analytics to generate reproducible search workflows for compound screening support.
• Reproducibility: Apply standardized search protocols across teams to ensure consistent literature inputs for assay development.

Translational & Preclinical Research

• Translational Continuity: Track yearly publication trends to align discovery findings with evolving clinical and translational research focus areas.
• Biomarker Alignment: Identify collaboration networks and disciplinary spread to assess biomarker relevance across disease models.
• Risk-Adjusted Advancement: Use open access and publication volume trends to inform preclinical investment decisions.

Pipeline & Workflow Integration

This method integrates into the discovery continuum by informing early biology through literature landscape analysis, supporting screening readiness via standardized search protocols, and enabling translational continuity through trend monitoring.

• Discovery Biology: Supports hypothesis testing by revealing publication density and evolution in specific biological pathways.
• Screening: Enhances assay readiness by providing reproducible, database-specific search strategies for compound-related literature.
• Analytics: Delivers quantitative outputs such as publication counts, collaboration networks, and open access metrics for comparative analysis.
• Translational Research: Connects discovery to preclinical work by tracking shifts in research focus and interdisciplinary engagement over time.
• Enterprise Reuse: Establishes a reusable literature surveillance capability applicable across projects, targets, and therapeutic areas.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in target selection by reducing uncertainty through comprehensive literature mapping.
• Operational Value: Ensures standardization and scalability of literature searches across global R&D sites using database-specific protocols.
• Strategic Value: Improves go/no-go decisions by providing quantitative insights into research trends and competitive activity.
• Portfolio Impact: Enables risk-adjusted prioritization by identifying emerging science and declining interest areas.

Implementation Considerations

• Requires expertise in database navigation and search syntax for PubMed, Scopus, and Web of Science.
• Depends on institutional access to subscription-based platforms and familiarity with advanced search features.
• Necessitates cross-team agreement on search terms, filters, and exclusion criteria for reproducible results.
• Involves adaptation of search fields (e.g., Affiliation vs. Address) based on database-specific metadata structures.
• Limited by database coverage biases, requiring complementary use of multiple platforms for comprehensive analysis.

Biopharma FAQs